Skip to main content
Premium Trial:

Request an Annual Quote

Stanley Lapidus

Aushon BioSystem has appointed Stanley Lapidus to its board of directors. He brings more than three decades of experience founding and leading breakthrough diagnostic companies. Lapidus founded and served as CEO for Cytyc, now part of Hologic, in the late 80's.  After Cytic, he founded Exact Sciences where he served as CEO until 2001 and chairman until 2005. He also was both founder and CEO of SynapDx and Helicos Biosciences.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.